HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N-homocysteine thiolactonyl retinamido cobalamin

Also Known As:

HTRC

Networked: 6 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Aitzetmüller, Matthias M: 1 article (06/2022)
2.	Glasbrenner, Johannes: 1 article (06/2022)
3.	Klietz, Marie-Luise: 1 article (06/2022)
4.	Langer, Martin F: 1 article (06/2022)
5.	Oeckenpöhler, Simon: 1 article (06/2022)
6.	Raschke, Michael J: 1 article (06/2022)
7.	Bucher, Florian: 1 article (11/2021)
8.	Dastagir, Khaled: 1 article (11/2021)
9.	Enechukwu, Anieto Onochie Matthias: 1 article (11/2021)
10.	Jokuszies, Andreas: 1 article (11/2021)

Related Diseases

1.	Atherosclerosis 08/01/1990 - "In order to study the relation of homocysteine and lipid metabolism to atherogenesis, rabbits were fed a synthetic atherogenic diet and treated with parenteral thioretinaco (N-homocysteine thiolactonyl retinamido cobalamin), thioretinamide (N-homocysteine thiolactonyl retinamide) or homocysteine thiolactone hydrochloride. "
2.	Wounds and Injuries (Trauma) 06/01/2022 - "We retrospectively analyzed all patients presenting at a FESSH accredited HTRC and level 1 trauma center in Germany during the Covid-19 lockdown period and an equivalent timeframe in 2019 regarding incidence of hand trauma, injury mechanism, type of injury and hand surgeries. " 11/01/2021 - "In the period from 2015 to 2020, 16 patients with various infections of the hand underwent 17 operations using WALANT in a Hand Trauma and Replantation Center (HTRC) in Germany. "
3.	Neoplasms (Cancer) 10/01/1989 - "A single dose of 2.5 mg/kg of the synthetic derivative, N-homocysteine thiolactonyl retinamido cobalamin, injected directly into subcutaneous human pancreatic adenocarcinoma neoplasms in athymic mice, caused 50% inhibition of growth without evidence of toxicity. " 09/01/1989 - "When the ethyl carbamate was given in a single dose of 20 mg/animal, all three substances produced significant mortality in doses of 0.75-30 mg/kg. In the survivors of this experiment, doses of 0.75-30 mg/kg of N-homocysteine thiolactonyl retinamido cobalamin decreased the number of pulmonary tumors induced by ethyl carbamate to 52-82% of controls (P less than 0.01). " 09/01/1989 - "A total dose of N-homocysteine thiolactonyl retinamido cobalamin of 60 mg/kg, given for a total of 16 weeks, decreased by one fourth (P less than 0.05) the number of pulmonary tumors induced by ethyl carbamate. "
4.	Carcinogenesis 09/01/1989 - "The results show that N-homocysteine thiolactonyl retinamido cobalamin has chemopreventive activity against chemical carcinogenesis by ethyl carbamate in mice." 09/01/1989 - "Chemopreventive effect of N-homocysteine thiolactonyl retinamido cobalamin on carcinogenesis by ethyl carbamate in mice."
5.	Infections 11/01/2021 - "In the period from 2015 to 2020, 16 patients with various infections of the hand underwent 17 operations using WALANT in a Hand Trauma and Replantation Center (HTRC) in Germany. "

Related Drugs and Biologics

1.	Homocysteine
2.	thioretinaco
3.	N-homocysteine thiolactonyl retinamide
4.	homocysteine thiolactone
5.	Urethane (Ethyl Carbamate)

Related Therapies and Procedures

1.	Replantation